Evidence map›Paper›PMID 35493149›Full record

ArticleRSC advances2021

Chemo- and regioselective cross-dehydrogenative coupling reaction of 3-hydroxycarbazoles with arenols catalyzed by a mesoporous silica-supported oxovanadium.

Kengo Kasama, Kyohei Kanomata, Yuya Hinami, Karin Mizuno, Yuta Uetake, Toru Amaya, Makoto Sako, Shinobu Takizawa, Hiroaki Sasai, Shuji Akai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kengo KasamaGraduate School of Pharmaceutical Sciences, Osaka University 1-6 Yamadaoka Suita Osaka 565-0871 Japan akai@phs.osaka-u.ac.jp.ORCID https://orcid.org/0000-0002-8157-3104
Kyohei KanomataGraduate School of Pharmaceutical Sciences, Osaka University 1-6 Yamadaoka Suita Osaka 565-0871 Japan akai@phs.osaka-u.ac.jp.ORCID https://orcid.org/0000-0002-2251-4665
Yuya HinamiGraduate School of Pharmaceutical Sciences, Osaka University 1-6 Yamadaoka Suita Osaka 565-0871 Japan akai@phs.osaka-u.ac.jp.
Karin MizunoGraduate School of Pharmaceutical Sciences, Osaka University 1-6 Yamadaoka Suita Osaka 565-0871 Japan akai@phs.osaka-u.ac.jp.
Yuta UetakeDivision of Applied Chemistry, Graduate School of Engineering, Osaka University 2-1 Yamadaoka Suita Osaka 565-0871 Japan.
Toru AmayaDivision of Applied Chemistry, Graduate School of Engineering, Osaka University 2-1 Yamadaoka Suita Osaka 565-0871 Japan.ORCID https://orcid.org/0000-0002-7716-0630
Makoto SakoSANKEN (The Institute of Scientific and Industrial Research), Osaka University Mihogaoka Ibaraki Osaka 567-0047 Japan.ORCID https://orcid.org/0000-0002-4268-7002
Shinobu TakizawaSANKEN (The Institute of Scientific and Industrial Research), Osaka University Mihogaoka Ibaraki Osaka 567-0047 Japan.ORCID https://orcid.org/0000-0002-9668-1888
Hiroaki SasaiSANKEN (The Institute of Scientific and Industrial Research), Osaka University Mihogaoka Ibaraki Osaka 567-0047 Japan.
Shuji AkaiGraduate School of Pharmaceutical Sciences, Osaka University 1-6 Yamadaoka Suita Osaka 565-0871 Japan akai@phs.osaka-u.ac.jp.ORCID https://orcid.org/0000-0001-9149-8745

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cross-dehydrogenative coupling between 3-hydroxycarbazoles and 2-naphthols has been achieved by using a mesoporous silica-supported oxovanadium catalyst.

Identifiers

PMID35493149
PMCPMC9042799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.